Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk?

Since the FDA first warned that ranitidine products may contain a potentially cancer-causing impurity, known as N-nitrosodimethylamine, numerous drugmakers have recalled their ranitidine products ...

CVS and Walgreens quit selling heartburn drug Zantac and generic ranitidine products during an ongoing FDA investigation into possible cancer risks.

Zantac, and all ranitidine products, should be removed from shelves, as the FDA cites carcinogen NDMA concerns.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

Drugmaker Novartis said it is halting distribution of all ranitidine medicines made by Sandoz, a measure it called “precautionary” after the acid-reducing medications were found to contain an ...

A few years ago, the small lab Valisure generated headlines after purportedly finding astronomical levels of the cancer-causing chemical NDMA in Zantac (ranitidine). The Food and Drug ...